Retinal Atrophy and Neurofilament Light Chain in People With Multiple Sclerosis Taking Ofatumumab
Retinal Atrophy and Neurofilament Light Chain in People With Multiple Sclerosis Taking Ofatumumab
Enrolling by invitation · NCT06167642 · Registry updated 2026-06-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Retinal Atrophy and Neurofilament Light Chain in People With Multiple Sclerosis Taking Ofatumumab | CNS demyelinating autoimmune disease, Eye Diseases, Hereditary, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, eye disorder, immune system disorder, multiple sclerosis, nervous system disorder, retinal degeneration, retinal disorder | Enrolling by invitation | Not stated | 2026-06-10 | NCT06167642 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Johns Hopkins University | 579 |
| Novartis | 114 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Johns Hopkins | Baltimore | United States | 39 |